FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Posted:
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
People with spinal cord injuries often lose the ability to move their arms or legs. In many cases, the nerves in the limbs remain healthy, and the brain continues to function normally. The loss of movement happens because damage to…
Artificial intelligence AI is becoming increasingly visible across oncology services, from diagnostics and treatment planning to administrative workflows. Cancer patients demonstrated a balanced view of artificial intelligence, combining awareness and openness with defined boundaries.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us